EUVIMEDTutustu EUVIMEDiin
Scoping ReviewOpen access

Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review

Digitale Tools für Menschen ohne Alzheimer-Erkrankung oder Demenzdiagnose: Scoping Review

Tanja J de Rijke iD, Thomas Engelsma iD, Chi Him Ng iD, Kyra Km Kaijser iD, Henk Herman Nap iD, Ellen Ma Smets iD, Leonie Nc Visser iD

Journal of Medical Internet Research · 2025-08-25 · 27 · e64862-e64862

DOI: 10.2196/64862 ↗

Auf einen Blick

Der Review fasst digitale Tools für Menschen ohne AD- oder Demenzdiagnose zusammen. Die meisten waren in frühen Entwicklungs- und Evaluationsphasen.

Fragestellung

Welche digitalen Tools wurden in der Literatur für Menschen ohne AD- oder Demenzdiagnose beschrieben, und wie weit sind sie entwickelt und evaluiert?

Methode

Scoping Review; Suche in PubMed, IEEE Xplore, Ovid und Web of Science im Januar 2023; 2 Reviewer sichteten 2811 Records und 408 Volltexte.

Ergebnisse

Eingeschlossen wurden 39 Artikel. Ziele: Primärprävention 14/39, Sekundärprävention 11/39, Alltagsunterstützung 8/39, Selbstscreening 4/39, Entscheidungsfindung 2/39. 31/39 Tools waren früh evaluiert bzw. entwickelt.

Einschränkungen

Ethnizität und digitale Gesundheitskompetenz wurden nur in wenigen Artikeln berichtet.

Schlussfolgerung der Autor:innen

Die in der Literatur beschriebenen digitalen Tools befinden sich überwiegend in frühen Entwicklungsphasen; weitere Entwicklung, Forschung und Politik sind erforderlich, bevor sie eingesetzt werden können.

Kernaussagen

  • 39 Artikel zu digitalen Tools ohne AD- oder Demenzdiagnose
  • 31/39 Tools in frühen Entwicklungs- und Evaluationsphasen
  • Wenig Angaben zu Ethnizität und digitaler Gesundheitskompetenz

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Scoping Review in Journal of Medical Internet Research, published online on 2025-08-25. Written by Tanja J de Rijke and 6 co-authors. Institution: Department of Medical Psychology, Amsterdam University Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands, …. Major MEDLINE topics: Alzheimer Disease, Dementia. Cited 7 times so far (Crossref); 113 references. The full text is freely available in PubMed Central.

Auf einen BlickTiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background

The field of Alzheimer disease (AD) has been moving toward earlier detection, personalized assessment of dementia risk, and dementia prevention. In the near future, a gap is expected between the growing demand for Alzheimer-related health care and a shrinking workforce. Responsibility is increasingly assigned to individuals to take an active role in their own brain health management and dementia prevention. Digital tools are thought to offer support regarding these processes.

Objective

The aim of this scoping review is to create an overview of digital tools published in scientific literature in the context of AD and dementia aimed at people without an AD or dementia diagnosis as primary end users interacting with these digital tools. Additionally, we aim to gain insight into study sample diversity, the stage of maturity and evaluation of these tools, and recommended future directions.

Methods

PubMed, IEEE Xplore, Ovid, and Web of Science were searched in January 2023, using terms related to AD and dementia, (pre-)disease stages, digital tools, and various purposes of digital tools. Two independent reviewers screened the titles and abstracts of 2811 records and subsequently 408 full-text articles, based on inclusion and exclusion criteria. Articles on tools targeting those with an AD or dementia diagnosis were excluded. Data extraction included information on the sample characteristics, the digital tool, stage of maturity and evaluation, and future (research) directions.

Results

We included 39 articles, which were aimed at primary prevention (14/39, 36%), secondary prevention (11/39, 28%), daily life support (8/39, 21%), self-administered screening (4/39, 10%), or decision-making (2/39, 5%). Variation in the study sample emerged regarding cognitive abilities (healthy: 11/39, 28%; mild cognitive impairment: 12/39, 31%; [subjective] cognitive impairment: 9/39, 23%; “no dementia”: 1/39, 3%; and variation of cognitive abilities: 6/39, 15%). Less variation was found regarding sex (>50% female: 27/39, 69%), education (>50% high education: 13/39, 33%), and age (>50% >60 y: 23/39, 59%). Few articles reported on ethnicity (12/39, 31%) and digital literacy (11/39, 28%). Most tools were in an early evaluation and maturity stage (31/39, 80%), comprising preprototyping (1/35, 3%), prototyping (15/35, 43%), pilot testing (19/35, 54%), efficacy testing (18/40, 45%), usability testing (12/40, 30%), and feasibility testing (10/40, 25%). Future (research) directions comprised the need for further tool development, attention to diversity, and study advancements, such as large-scale longitudinal studies.

Conclusions

Almost 80% of tools as reported on in academic literature are in early development comprising early stages of maturity and evaluation. Studies and evidence gathered for digital tools developed in the context of AD or dementia aimed at people without an AD or dementia diagnosis are thus preliminary and further development, research, and policy are required before these tools can be implemented for assessing, supporting, and preventing cognitive decline.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseDementiaHumans

Author keywords

brain healthdigital toolsdiversityeHealthelectronic healthequityfuture directionsimpact evaluationimplementationmHealthmobile healthstage of maturity

Authors and institutions

  • Department of Medical Psychology, Amsterdam University Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands, 31 205663622.
  • Personalized Medicine, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
  • Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Neurodegeneration, Amsterdam Neuroscience Research Institute, Amsterdam, The Netherlands.
  • Digital Health, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
  • eHealth Living & Learning Lab Amsterdam, Department of Medical Informatics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

ORCID profiles: Tanja J de Rijke, Thomas Engelsma, Chi Him Ng, Kyra Km Kaijser, Henk Herman Nap, Ellen Ma Smets, Leonie Nc Visser

Cite

APA

de Rijke, T. J., Engelsma, T., Ng, C. H., Kaijser, K. K., Nap, H. H., Smets, E. M., & Visser, L. N. (2025). Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review. Journal of Medical Internet Research, 27, e64862-e64862. https://doi.org/10.2196/64862

Vancouver

de Rijke TJ, Engelsma T, Ng CH, Kaijser KK, Nap HH, Smets EM, et al. Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review. Journal of Medical Internet Research. 2025;27:e64862-e64862. doi:10.2196/64862

BibTeX
@article{deRijke2025,
  author = {de Rijke, Tanja J and Engelsma, Thomas and Ng, Chi Him and Kaijser, Kyra Km and Nap, Henk Herman and Smets, Ellen Ma and Visser, Leonie Nc},
  title = {Digital Tools for People Without an Alzheimer Disease or Dementia Diagnosis: Scoping Review},
  journal = {Journal of Medical Internet Research},
  year = {2025},
  volume = {27},
  pages = {e64862--e64862},
  doi = {10.2196/64862}
}
Start for free →